Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension

American Journal of Hypertension

Volumn 22, Issue 5, 2009, Pages 484-492

  Oliveira Sales, Elizabeth B ^a   Nishi, Erika E ^a   Carillo, Bruno A ^a   Boim, Mirian A ^a   Dolnikoff, Miriam S ^a   Bergamaschi, Cássia T ^a   Campos, Ruy R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; COPPER ZINC SUPEROXIDE DISMUTASE; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROL GROUP; CONTROLLED STUDY; MALE; MEAN ARTERIAL PRESSURE; MOTONEURON; NERVE CELL STIMULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; SYMPATHETIC NERVE; THALAMUS MIDLINE NUCLEUS; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CYCLIC N-OXIDES; HYPERTENSION, RENOVASCULAR; MALE; MEDULLA OBLONGATA; MEMBRANE GLYCOPROTEINS; MOTOR NEURONS; NADPH OXIDASE; OXIDATIVE STRESS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; SPIN LABELS; SUPEROXIDE DISMUTASE; SYMPATHETIC NERVOUS SYSTEM;

EID: 67349247022     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.17     Document Type: Article

References (42)

1. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, Dominiczak AF. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000; 101:2206-2212.
2. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74:1141-1148.
3. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, Davisson RL. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 2004; 95:532-539.
4. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285:R277-R297.
5. Groemping Y, Lapougue K, Smerdon SJ, Rittinger K. Molecular basis of phosphorylation-induced activation of the NAD(P)H oxidase. Cell 2003; 113: 343-355.
6. Campos RR, Bergamaschi CT. Neurotransmission alterations in central cardiovascular control in experimental hypertension. Curr Hypertens Rev 2006; 2:193-198.
7. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74:323-364.
8. Badoer E. Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol 2001; 28:95-99.
9. Coote JH, Yang Z, Pyner S, Deering J. Control of sympathetic outflows by the hypothalamic paraventricular nucleus. Clin Exp Pharmacol Physiol 1998; 25: 461-463.
10. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 2005; 288:H2271-H2279.
11. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 2004; 45: 717-723.
12. Erdös B, Broxson CS, King MA, Scarpace PJ, Tümer N. Acute pressor effect of central angiotensin II is mediated by NAD(P)H-oxidase- dependent production of superoxide in the hypothalamic cardiovascular regulatory nuclei. J Hypertens2006; 24:109-116.
13. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q IV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997; 80:45-51.
14. Oliveira-Sales EB, Dugaich APC, Carillo BA, Abreu AP, Boim AP, Martins PJF, D'Almeida V, Dolnikoff MS, Bergamaschi CT, Campos RR. Oxidative stress contributes to renovascular hypertension. Am J Hypertens 2008; 21:98-104.
15. Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2α. Hypertension1999; 33(1 Pt 2):424-428.
16. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998; 32:59-64.
17. Bergamaschi C, Campos RR, Schor N, Lopes OU. Role of the rostral ventrolateral medulla in maintenance of blood pressure in rats with Goldblatt hypertension. Hypertension 1995; 26:1117-1120.
18. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd edn. New York, NY: Academic Press Inc, 1986.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ Ct) method. Methods 2001; 25:402-408.
20. Yang Z, Coote JH. Paraventricular nucleus influence on renal sympathetic activity in vasopressin gene-deleted rats. Exp Physiol 2007; 92:109-117.
21. Dampney RA, Fontes MA, Hirooka Y, Horiuchi J, Potts PD, Tagawa T. Role of angiotensin II receptors in the regulation of vasomotor neurons in the ventrolateral medulla. Clin Exp Pharmacol Physiol 2002; 29:467-72. Review.
22. Phillips MI, Sumners C. Angiotensin II in central nervous system physiology. Regul Pept 1998; 78:1-11.
23. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: implications for long term control of autonomic output. Clin Exp Pharmacol Physiol 1997; 24:96-101.
24. Ku YH, Jia YF, Chang YZ. Mechanisms underlying pressor response of subfornical organ to angiotensin II. Peptides 1999; 20:171-176.
25. Potts PD, Hirooka Y, Dampney RA. Activation of brain neurons by circulating angiotensin II: direct effects and baroreceptor-mediated secondary effects. Neuroscience 1999; 90:581-594.
26. Li JM, Shah AM. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem 2003; 278:12094-12100.
27. Modlinger P, Chabrashvili T, Gill PS, Mendonca M, Harrison DG, Griendling KK, Li M, Raggio J, Wellstein A, Chen Y, Welch WJ, Wilcox CS. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 2006; 47: 238-244.
28. Peterson J, Burmeister MA, Tian X, Stupinski JA, Sharma VA, Davisson RL. Both Nox2- and Nox4-containing NAD(P)H oxidases are required for the full vasopressor effects of angiotensin-II (Ang-II) in the central nervous system. FASEB J 2007; 21:752.1.
29. Chan SH, Hsu KS, Huang CC, Wang LL, Ou CC, Chan JY. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res2005; 97:737-739.
30. Chan SH, Tai MH, Li CY, Chan JY. Reduction inmolecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med2006; 40:2028-2039.
31. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation2004; 109:2357-2362.
32. Zanzinger J, Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflugers Arch 2000; 439:489-494.
33. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271(5 Pt 1):C1424-C1437. Review.
34. Gokce N, Keaney JF Jr, Frei B, Holbrook M, Olesiak M, Zachariah BJ, Leeuwenburgh C, Heinecke JW, Vita JA. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999; 99:3234-3240.
35. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997; 95:2617-2622.
36. Guron GS, Grimberg ES, Basu S, Herlitz H. Acute effects of the superoxide dismutase mimetic tempol on split kidney function in two-kidney one clip hypertensive rats. J Hypertension 2006; 24:387-394.
37. Xu H, Fink GD, Chen A, Watts S, Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in normotensive rats. Am J Physiol Heart Circ Physiol 2001; 281:H975-H980.
38. Xu H, Fink GD, Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol 2002; 283:H885-H892.
39. Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 2003; 41:1346-1352.
40. Xu H, Fink GD, Galligan JJ. Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2- in DOCA-salt rats. Hypertension 2004; 43:329-334.
41. Samuni A, Mitchell JB, DeGraff W, Krishna CM, Samuni U, Russo A. Nitroxide SODmimics: modes of action. Free Radic Res Commun 1991; 12-13(Pt 1):187-194.
42. Offer T, Russo A, Samuni A. The pro-oxidative activity of SOD and nitroxide SOD mimics. FASEB J 2000; 14:1215-1223.